What will help marijuana stock investors trade more, even in the midst of laws changing in the USA? It is no secret that nothing has moved pot stocks more than news of global reform or regulatory matters. For the US, what happens at the federal level has moved the needle the most, with the recent passing of legislation to reclassify cannabis to Schedule 3.
Cresco Labs Inc. (CRLBF) Q2 2026 Earnings Call Transcript
Cresco Labs Inc. (CRLBF) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to a loss of $0.05 per share a year ago.
| Diversified Consumer Services Industry | Consumer Discretionary Sector | Charles Bachtell CEO | XFRA Exchange | CA22587M1068 ISIN |
| US Country | 2,900 Employees | - Last Dividend | 3 Dec 2018 Last Split | - IPO Date |